Trials / Withdrawn
WithdrawnNCT01123122
A Comparison of Strict Glucose Control With Usual Care at the Time of Islet Cell Transplantation
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Vancouver Coastal Health · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Islet transplants for those with type 1 diabetes have enabled many to initially eliminate insulin, however, only a fraction of the transplanted cells typically survive and the functioning of these decrease over time. As a result, most patients will eventually require some insulin. Currently, the cause of this poor survival and decrease in function is not understood; although previous research has demonstrated that even a slightly elevated level of blood glucose can impair islet function. This study will determine if strict blood glucose control at the time of islet transplantation, when the cells are the most fragile, will improve the survival and functioning of transplanted islet cells three months after transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Strict glucose control | Blood glucose level to be maintained at 4-6 mmol/L at the time of islet transplantation until two weeks post-transplantation. |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2010-05-14
- Last updated
- 2015-04-01
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01123122. Inclusion in this directory is not an endorsement.